United States · FDA National Drug Code directory
Quetiapine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-247_1324eb95-6488-498f-b2c9-1c44b1f48062
- Product NDC
- 67877-247
- Form
- TABLET, FILM COATED
- Composition / generic term
- Quetiapine
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20130301
- Source listing expiry
- 20271231
Source-listed ingredients
- QUETIAPINE FUMARATE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET, FILM COATED in 1 BOTTLE (67877-247-10) · 67877-247-10
- 1 BLISTER PACK in 1 CARTON (67877-247-33) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 67877-247-33
- 10 BLISTER PACK in 1 CARTON (67877-247-38) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 67877-247-38
- 60 TABLET, FILM COATED in 1 BOTTLE (67877-247-60) · 67877-247-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →